<SEC-DOCUMENT>0001564590-22-019094.txt : 20220510
<SEC-HEADER>0001564590-22-019094.hdr.sgml : 20220510
<ACCEPTANCE-DATETIME>20220510084716
ACCESSION NUMBER:		0001564590-22-019094
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220510
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220510
DATE AS OF CHANGE:		20220510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lyra Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001327273
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39273
		FILM NUMBER:		22907543

	BUSINESS ADDRESS:	
		STREET 1:		480 ARSENAL WAY
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-373-4600

	MAIL ADDRESS:	
		STREET 1:		480 ARSENAL WAY
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	480 Biomedical, Inc.
		DATE OF NAME CHANGE:	20120927

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Arsenal Vascular, Inc.
		DATE OF NAME CHANGE:	20110826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Arsenal Medical, Inc.
		DATE OF NAME CHANGE:	20090414
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lyra-8k_20220510.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-09T23:45:18.0373442+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : cce1d8423df64e7f9cba5ad91da6fb82 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:lyra="http://lyratherapeutics.com/20220510" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
lyra-8k_20220510.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001327273_20220510_20220510">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001327273_20220510_20220510">0001327273</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="lyra-20220510.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001327273_20220510_20220510">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001327273</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-05-10</xbrli:startDate>
					<xbrli:endDate>2022-05-10</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-top:Double 2.25pt;padding-top:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549 </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001327273_20220510_20220510">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001327273_20220510_20220510" format="ixt:datemonthdayyearen">May 10, 2022</ix:nonNumeric></p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001327273_20220510_20220510">LYRA THERAPEUTICS, INC.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter) </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityFileNumber" contextRef="C_0001327273_20220510_20220510">001-39273</ix:nonNumeric></p></td>
<td valign="bottom" style="width:33.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001327273_20220510_20220510">84-1700838</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td valign="bottom" style="width:33.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr>
<td valign="bottom" style="width:33.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:33.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:33.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine1" contextRef="C_0001327273_20220510_20220510">480 Arsenal Way</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001327273_20220510_20220510">Watertown</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001327273_20220510_20220510">MA</ix:nonNumeric> <ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001327273_20220510_20220510">02472</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices) (Zip Code)</p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001327273_20220510_20220510">617</ix:nonNumeric>) <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001327273_20220510_20220510">393-4600</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, include area code) </p>
<p style="text-align:center;margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N/A</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report) </p>
<p style="text-align:center;margin-top:9pt;line-height:4pt;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:6pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:38%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001327273_20220510_20220510">Common Stock, $0.001 par value per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:15%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0001327273_20220510_20220510">LYRA</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:45%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000006" name="dei:EntityExTransitionPeriod" contextRef="C_0001327273_20220510_20220510" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 2.02. Results of Operations and Financial Condition.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 10, 2022, Lyra Therapeutics, Inc. (the &#8220;Company&#8221;) announced its financial results for the quarter ended March 31, 2022. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information contained in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01. Financial Statements and Exhibits.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="middle" style="width:93%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:auto;white-space:nowrap;">
<p style="text-align:center;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br />No.</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom" style="width:auto;white-space:nowrap;">
<p style="border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:4pt;">
<td valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="lyra-ex991_24.htm"><span style="text-decoration:underline;">Press Release issued on May 10, 2022</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td>
</tr>
</table></div>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="middle" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="middle" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LYRA THERAPEUTICS, INC.</p></td>
</tr>
<tr style="height:8pt;">
<td valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: May 10, 2022</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:1pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Jason Cavalier</p></td>
</tr>
<tr>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jason Cavalier</p></td>
</tr>
<tr>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lyra-ex991_24.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
lyra-ex991_24.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3lbc3eihy1c000001.jpg" title="" alt="" style="width:142px;height:57px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Lyra Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update</font></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">&nbsp;</font></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:12pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">In April 2022, secured $100.5 million in gross proceeds in an at-the-market, private placement of common stock that is expected to support two pivotal data readouts; cash runway extended until mid-2024</font></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:0%;font-style:italic;font-size:12pt;font-family:Calibri;font-weight:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Pivotal ENLIGHTEN Phase 3 clinical program and BEACON Phase 2 clinical trial targeting a broad spectrum of CRS patients actively recruiting patients</font></p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:0pt;margin-bottom:0pt;margin-left:3.85%;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">WATERTOWN, Mass.,&#160;May 10, 2022 &#8211; Lyra Therapeutics, Inc.&#160;(Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo&#8482; platform to enable precise, sustained and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today reported financial results for the first quarter ended&#160;March 31</font>, <font style="Background-color:#FFFFFF;">2022, and highlighted recent accomplishments.</font></p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;"><a name="_Hlk65756736"></a>&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">&#8220;The first quarter marked progress in our two ongoing clinical programs: the pivotal ENLIGHTEN Phase 3 program and the BEACON Phase 2 trial, both of which are actively recruiting patients with chronic rhinosinusitis,&#8221; said Maria Palasis, PhD, President and Chief Executive Officer of&#160;Lyra Therapeutics.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">&#8220;The recent capital raise of approximately $100.5 million in an at-the-market private placement of common stock is expected to fund several important milestones in our ongoing clinical programs, including pivotal data readouts for ENLIGHTEN I and ENLIGHTEN II trials for LYR-210, as well as the topline data readout in the BEACON Phase 2 trial for LYR-220. Given today&#8217;s challenging capital markets, we view the robust investor support in the recent financing as a testament to our compelling product candidates that have the potential to change the treatment paradigm in the estimated&#160;$6 billion&#160;target addressable market for CRS patients,&#8221; said Dr. Palasis. </font></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Corporate Highlights </font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">In April 2022, Lyra closed a private placement of common stock of approximately $100.5 million in gross proceeds with participation by funds affiliated with existing investors: Perceptive Advisors,&#160;North Bridge Venture Partners&#160;and Pura Vida Investments as well as funds affiliated with new investors:&nbsp;&nbsp;Venrock Healthcare Capital Partners, Nantahala Capital Management, LLC&#160;and Samsara BioCapital.&nbsp;&nbsp; The proceeds, combined with the Company&#8217;s existing cash balance and anticipated milestones, under its license agreement with LianBio, is expected to provide sufficient operating capital through mid-2024. </font></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Clinical Developments for LYR-210 and LYR-220</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">At the 2022 Combined Otolaryngology Spring Meetings (COSM), two oral presentations were presented that highlighted additional positive clinical data from the LANTERN Phase 2 trial of LYR-210 in adult patients with chronic rhinosinusitis (CRS). The Company&#8217;s oral presentation on the impact of long-acting implantable corticosteroid matrices in CRS patients was selected as a top clinical abstract by the American Rhinologic Society. A second presentation highlighted </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3lbc3eihy1c000001.jpg" title="" alt="" style="width:142px;height:57px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">clinically meaningful </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">improv</font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">ement in mental and physical </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">quality of life </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">outcomes </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">for CRS patients</font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">. These results are supportive of the previously reported, statistically significant </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">40</font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">-point improvement for LYR-210 (7500&#181;g) over </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">the average baseline</font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;"> SNOT-22 score </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">of 68 </font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">at week 24.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:11pt;font-family:Calibri;">Enrollment in the pivotal ENLIGHTEN I Phase 3 trial is ongoing, while the initiation of the ENLIGHTEN II Phase 3 trial is targeted to begin mid-year. Both ENLIGHTEN trials are expected to enroll patients in the U.S. and Europe.&nbsp;&nbsp;The global ENLIGHTEN Phase 3 program is expected to include a total of 360 adult, surgically-na&#239;ve CRS patients and enrollment is on track to be completed in the first half of 2023.&nbsp;&nbsp;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;">Last month, the first patient was treated in Australia in the Part 1/non-randomized portion of the BEACON Phase 2 trial for LYR-220 for the treatment of adult CRS patients who remain symptomatic despite having had a prior sinus surgery. The Part 2/randomized portion of the trial is anticipated to commence in the U.S. later in the second quarter. The BEACON Phase 2 trial is expected to include approximately 70 symptomatic adult CRS subjects who have had a prior sinus surgery, with enrollment anticipated to be complete around the end of 2022.  Topline results from the Part 1/non-randomized portion of the trial are anticipated around year-end. </font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">First Quarter 2022 Financial Highlights </font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;">Cash and cash equivalents as of&#160;March 31, 2022&#160;were&#160;$33.8 million, compared with&#160;$45.7 million&#160;at&#160;December 31, 2021, and Lyra received an additional $100.5 million of gross proceeds from the April 2022 private placement. The Company expects its cash balance to be sufficient to fund its planned operations through mid-2024.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;">Research and development expenses for the quarter ended&#160;March 31, 2022&#160;were&#160;$8.5 million&#160;compared to&#160;$4.8 million&#160;for the same period in 2021. </font><font style="color:#000000;">The increase was primarily driven by an increase in clinical expenses, product development and manufacturing expenses, employee-related expenses and consulting costs related to the Company&#8217;s three clinical trials.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;">General and administrative expenses for the first quarter 2022 were&#160;$3.9 million&#160;compared to&#160;$3.1 million&#160;for the same period in 2021. </font><font style="color:#000000;">The increase was primarily driven by an increase in professional and consulting expenses and employee related costs.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;">Total operating expenses for the quarter ended&#160;March 31, 2022&#160;were&#160;$12.4 million&#160;compared to&#160;$7.8 million&#160;for the same period in 2021.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;">Net loss for the first quarter 2022 was&#160;$7.0 million&#160;compared to&#160;$7.8 million&#160;for the same period in 2021.</font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:6pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">About&#160;Lyra Therapeutics</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Lyra Therapeutics, Inc.&#160;is a clinical-stage therapeutics company leveraging its proprietary XTreo&#8482; platform to enable precise, sustained, local delivery of medications to diseased tissues not accessible with conventional therapeutic approaches. Lyra's XTreo&#8482; platform is comprised of a biocompatible mesh scaffold, an engineered elastomeric matrix and a versatile polymer-drug complex. The company's current pipeline of therapeutics target tissues deep in the ear, nose and throat passages and are designed to deliver continuous drug therapy for up to six months following a single non-invasive, in-</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3lbc3eihy1c000001.jpg" title="" alt="" style="width:142px;height:57px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">office administration. Lyra has two product candidates in late-stage development for CRS, a highly prevalent inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities: LYR-210, for surgically na&#239;ve patients is being evaluated in the ENLIGHTEN Phase 3 clinical program, and LYR-220, is being evaluated in patients who have recurrent symptoms despite surgery in the BEACON Phase 2 clinical </font><font style="Background-color:#FFFFFF;">trial</font><font style="Background-color:#FFFFFF;">. These two product candidates are designed to treat the estimated four million CRS patients in the&#160;U.S.&#160;that fail medical management each year. For more information, please visit&#160;</font><font style="Background-color:#FFFFFF;">www.lyratherapeutics.com</font><font style="Background-color:#FFFFFF;">&#160;and follow us on&#160;</font><font style="Background-color:#FFFFFF;text-decoration:underline;">LinkedIn</font><font style="Background-color:#FFFFFF;"> </font><font style="Background-color:#FFFFFF;">and </font><font style="Background-color:#FFFFFF;text-decoration:underline;">Twitter</font><font style="Background-color:#FFFFFF;">.</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Forward-Looking Statements</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Calibri;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding our cash runway through 2024 and the use of proceeds from the April private placement, our pipeline of product candidates, the enrollment and success of the ENLIGHTEN II Phase 3 program, the enrollment and success of the Phase 2 BEACON trial<font style="Background-color:#FFFFFF;"> (including the timelines for commencement of the Part 2/randomized portion of the trial in the U.S. later in the second quarter</font> and topline<font style="Background-color:#FFFFFF;"> results from the Part 1/non-randomized portion of the trial around year-end), </font>the success of the <font style="Background-color:#FFFFFF;">XTreo&#8482; platform, </font>and our ability to capture market share in the estimated $6 billion addressable market.<font style="Background-color:#FFFFFF;"> These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the fact that the company has incurred significant losses since inception and expects to incur losses for the foreseeable future; the company's need for additional funding, which may not be available; the company's limited operating history; the fact that the company has no approved products; the fact that the company's product candidates are in various stages of development; or the fact that the company may not be successful in its efforts to identify and successfully commercialize its product candidates; the fact that clinical trials required for the company's product candidates are expensive and time-consuming, and their outcome is uncertain; the fact that the FDA may not conclude that certain of the company's product candidates satisfy the requirements for the Section 505(b)(2) regulatory approval pathway; the company's inability to obtain required regulatory approvals; effects of recently enacted and future legislation; the possibility of system failures or security breaches; effects of significant competition; the fact that the successful commercialization of the company's product candidates will depend in part on the extent to which governmental authorities and health insurers establish coverage, adequate reimbursement levels and pricing policies; failure to achieve market acceptance; product liability lawsuits; the fact that the company relies on third parties for the manufacture of materials for its research programs, pre-clinical studies and clinical trials; the company's reliance on third parties to conduct its preclinical studies and clinical trials; the company's inability to succeed in establishing and maintaining collaborative relationships; the company's reliance on certain suppliers critical to its production; failure to obtain and maintain or adequately protect the company's intellectual property rights; failure to retain key personnel or to recruit qualified personnel; difficulties in managing the company's growth; effects of natural disasters, terrorism and wars (including the developing conflict between&#160;Ukraine&#160;and&#160;Russia); the fact that the global pandemic caused by COVID-19 could adversely impact the company's business and operations, including the company's clinical trials; the fact that the price of the company's common stock may be volatile and fluctuate substantially; significant costs and required management time as a result of operating as a public company and any securities class action litigation. These and other important </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3lbc3eihy1c000001.jpg" title="" alt="" style="width:142px;height:57px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-style:italic;font-family:Calibri;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">factors discussed under the caption "Risk Factors" in the company's </font><font style="Background-color:#FFFFFF;">Quarterly </font><font style="Background-color:#FFFFFF;">Report on Form 10-</font><font style="Background-color:#FFFFFF;">Q </font><font style="Background-color:#FFFFFF;">filed with the&#160;SEC&#160;on&#160;</font><font style="Background-color:#FFFFFF;">May 10</font><font style="Background-color:#FFFFFF;">, </font><font style="Background-color:#FFFFFF;">2022</font><font style="Background-color:#FFFFFF;">&#160;and its other filings with the&#160;SEC&#160;could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While the company may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, even if subsequent events cause its views to change.</font><font style="font-size:12pt;font-family:Times New Roman;font-style:normal;"> </font></p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Investor Contact:<br />Argot Partners<br />212-600-1902<br />lyra@argotpartners.com</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Media Contact:<br />Kathryn Morris<br />914-204-6412<br />kathryn@theyatesnetwork.com</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LYRA THERAPEUTICS, INC. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR"></a><a name="CONSOLIDATED_STATEMENTS_OPERATIONS_COMPR"></a>Condensed Consolidated Statements of Operations</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(unaudited)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share data) </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr style="height:1pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;"><a name="_fbca195c_75c9_4371_8e9e_67baa668b76f"></a><a name="_eb4ca57b_8ab4_4a42_9921_437422ce9f5a"></a><a name="_d66d7710_4a90_46c9_bd62_5c3431957340"></a><a name="_cb0a9007_4c5d_4f19_b486_6de38ccc4118"></a><a name="_e0a885f2_5363_45b2_8673_e81f3530f383"></a><a name="_47b62536_c6f9_45ab_8322_f6b3bd2d54b2"></a><a name="_eebc214f_c210_4aa2_9f97_7c89a90559cd"></a><a name="_9cbff3e6_6faf_428a_bce7_dc62e0894414"></a><a name="_22d287c3_3946_43dd_908d_9c55c65a445b"></a><a name="_2cd7c1ee_96f3_47ab_a0c4_accac2789dcf"></a><a name="_ccfe9b7e_943f_4947_8cd6_802a3a9e070f"></a><a name="_b65cb733_1793_4b06_b407_3c8e8a2a43b1"></a><a name="_cf2032c2_d60a_46ff_bf9c_9fa83894b01d"></a><a name="_a44a0d7d_3705_4a6d_b834_8b42e463a9df"></a><a name="_2e9bc9e3_f04b_4b68_83b3_85b2662c3bbb"></a><a name="_b41ec224_af1b_4694_8990_1c0db5f45c92"></a>&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"><a name="_25117224_2320_486f_91aa_d33744fc9a78"></a><a name="_843f82c2_837b_494e_b02d_81a2e2286a0d"></a><a name="_bf838ca6_8c74_44c5_b625_7756c620ba75"></a><a name="_3f6dca4f_b0d0_4c77_96e8_c9764946338e"></a><a name="_057bb534_4154_4849_ac93_be4aa320cedb"></a><a name="_82d55f88_bc95_4dd3_b458_64e1c9dc14e1"></a><a name="_b5fb80e1_c433_47d8_8292_f7cf0feb5718"></a><a name="_e1496ea1_9712_4f70_9c19_d6089b4ebc7d"></a><a name="_97eabe49_7ba7_4fd5_b7c0_3d029013ab84"></a><a name="_8a132909_32e6_44dc_a4e6_43d07bddedbd"></a><a name="_6a698a95_581b_4c69_8846_acd476d0cfea"></a><a name="_9b5d2612_3baa_4779_933d_d3a75bb2ab88"></a><a name="_42ff9d53_dd26_4688_9b89_e74c805ae4e4"></a><a name="_feb6f03f_bb89_4336_9d8a_01466946041c"></a><a name="_98e2541d_13e2_4f12_8bff_9499c4f0cde6"></a><a name="_2dca1378_8b80_4cd5_8a48_2c383d2f7fa5"></a><a name="_e2c5def5_56eb_46e3_bbc9_4c8d716da58f"></a><a name="_8970a815_7f55_40a7_84c0_b22a36338608"></a><a name="_eade7272_0169_438e_a8b3_05b1ba669bd7"></a><a name="_4af4957d_2b6f_4657_951c_23ccadfa28ca"></a><a name="_f8c017ad_11f2_45b0_ae05_95dd27505b82"></a>&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaboration revenue</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,367</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,505</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,770</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,888</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,061</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,393</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,831</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,026</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,831</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income:</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other income</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,012</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,802</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to common stockholders&#8212;basic and diluted</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.54</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.60</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average common shares outstanding&#8212;basic and diluted</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,008,779</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,945,546</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LYRA THERAPEUTICS, INC. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="CONSOLIDATED_BALANCE_SHEETS"></a>Condensed <a name="CONSOLIDATED_BALANCE_SHEETS"></a>Consolidated Balance Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(unaudited)</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except share and per share data) </p>
<p style="text-align:center;margin-bottom:6pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr style="height:1pt;">
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;"><a name="_e6cd7d3a_9cc3_4ac2_9486_0f96f6299074"></a><a name="_d41d7b8c_a485_4b81_9591_a56facbcf0d3"></a><a name="_3bd57e32_7077_4707_873d_60c0f714458f"></a><a name="_6324516f_cc61_4110_9bca_26e48d52bdea"></a><a name="_ab70d386_1d6a_451a_b04b_831c7cef68ff"></a><a name="_4947b4d8_91f3_468e_9c66_4958baaa420c"></a><a name="_fce51c7f_5254_4e6e_b164_f99672c064b0"></a><a name="_b22c26b1_416b_40ce_bbf2_f178684d9531"></a><a name="_b5c7b87b_a803_4c4a_8d56_4059ee7d788b"></a><a name="_eb3fb5ad_ede8_4535_b398_32312cfa9deb"></a><a name="_842e2988_abb3_4ffc_afc3_9a820ef4598e"></a><a name="_39d05e28_fc1c_428e_afce_2205a62646ac"></a><a name="_a1957cd3_ee94_4baa_9214_90688e7f2f20"></a><a name="_a70cdd33_d65d_4e5d_bf41_e811dc24cd7e"></a><a name="_b562ed62_e8db_4ab5_8748_0d67f23f6af6"></a><a name="_b8ec3ac5_8ec4_43ea_bf70_b8c232a95553"></a><a name="_321d4bb9_e8ac_4eba_b583_be034af6f40f"></a><a name="_b23a30d4_973f_4b4d_9e45_07f5656bb417"></a><a name="_fa965250_098b_46e7_a7c3_dbe8e3c65375"></a><a name="_044fa0e3_1fba_4728_b508_8f113a6d6962"></a><a name="_33be8e14_727c_4feb_9316_a5b222fcc09b"></a><a name="_dabd0e2f_edd9_4d67_97f9_702a46ddfd97"></a><a name="_9865bcc0_03c2_4dd7_bdd2_df7f7f8abb99"></a><a name="_433c5fe4_284e_4557_a351_933e875be93f"></a><a name="_4cc3fe12_163d_49c7_b93e_8dbd175b3af7"></a><a name="_913fff02_1ed4_4921_83ca_41fe31040bc7"></a><a name="_f740b894_c5fc_458b_87ea_47b119c5cceb"></a><a name="_85ed8367_1298_4cc6_bed8_95b49362380d"></a><a name="_f09230d6_e7ef_4535_946a_4a52aba73be3"></a>&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7.5pt;"><a name="_b053e6f8_f9d7_4918_981e_b064397894fe"></a><a name="_f5b12c00_e7ec_420c_8073_fd001e393b06"></a><a name="_c06f3729_14e1_48ae_a986_4dfcfbcee20c"></a><a name="_b080c2e1_b121_4a73_b7ed_1bc2aa5c02a4"></a><a name="_b66871af_0098_4d82_949f_50e662c8df3a"></a><a name="_0a5d6546_21a3_4c51_864a_d8adb730c05d"></a><a name="_a17b98ce_0ec1_4af0_a759_c8ff9e071cde"></a><a name="_da099412_d79c_4985_9ab3_4b0fc759ae9c"></a><a name="_e47c1695_d904_4116_a2af_6bc273f3107a"></a><a name="_f9180999_7cc8_4b92_9348_66d823d3dea3"></a><a name="_7880ad5a_b7ba_4268_91f0_6456eac242f0"></a><a name="_0fa39464_bec5_405d_b0f3_71ee931a306d"></a><a name="_6c7dfb98_5f98_43f9_8620_db1623148699"></a><a name="_f0069cc0_d986_44da_8b85_4ed192fb4a28"></a><a name="_70321e0f_0202_49b4_88d7_bf1e5bccdff9"></a><a name="_ac1097ba_ccab_4020_b74a_af7aa6b796f7"></a><a name="_10e02f59_7e6d_402b_8d2e_2d153c4c270e"></a><a name="_126ed543_40d4_465d_8816_ee1ec7ae4b64"></a><a name="_c48c08c1_a8cc_424a_95ef_917ed26932ac"></a><a name="_8c65e721_6c76_433f_a852_02e262d2f45e"></a><a name="_758befe6_7ac3_40ab_812e_57c5ecdd31b3"></a>&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.06%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31,</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.04%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.04%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,755</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,747</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaboration revenue receivable</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,800</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,171</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,555</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,918</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,275</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,503</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,109</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,355</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">329</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">329</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,077</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,345</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,867</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities and Stockholders&#8217; Equity</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,408</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,125</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,237</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,258</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,097</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,074</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,060</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,789</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,802</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,246</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, net of current portion</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">379</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, net of current portion</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,926</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,189</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,551</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.5pt;;margin-right:4.27%;text-indent:-13.5pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2022 and December 31, 2021; 13,009,896 and 13,007,178 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">228,552</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">227,700</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.94%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(200,409</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(193,397</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,156</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,316</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.9%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,345</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,867</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g3lbc3eihy1c000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3lbc3eihy1c000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "U ;X# 2(  A$! Q$!_\0
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MEI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "HY.WX_P!*DJ.3M^/]* 'CH/H/Y4M(
M.@^@_E7/>)?%GA[PAITFJ>(]5M-*LHP29KJ58U..H7<1DTTFW9)MO9)79%2I
M3I0E4JSA3IP3E.I.2A"$5NY2DTHI=V['145Y3X/^-GPS\=WAT_PUXKTO4+T$
MXMHKF,R/@X^4!N3QP*]6H<91TDFGYJQGA\5AL935;"8BCB:3;7M*%2%6%UNN
M:#:NNU[A1112-PHHHH **** "BBLG6->T;0+8WFM:E9Z9:CK/>3+#'^;&C5Z
M)79,IQA%SG*,(15Y2DU&,4MVY.R2\VS6HKF-#\:^$_$K%= \0Z5JSKG*65W'
M*XQU^0$-Q]*Z>C5:-68J=6G6@JE*I"K![3IRC.#])1;3^\****"PHHHH ***
M* "BBB@ HHHH **RM7US1]!MC>:UJ5GIEJ,YGO)T@CXY/+D9P.N.E9>A>-O"
M/B9VCT#Q#I6K.OWDLKJ.5Q_P$$'\A3L[7L[=[.WWF4L10C4C1E6I1K2UC2E4
M@JDO\,&^9_)'4T44C,%4LQ"JH+,Q. J@9))/  '))Z"D:BT5Y%XI^.WPJ\'3
MFVUWQEH]K<*2KP_:XB\; X(?#<$8Z<UR/_#5GP._Z'G2/_ F/_&M%2J-)JG-
MI[-1?=+]3RZN>9-0J2I5LUR^E4B[2A/%T(RB^SBYW3\GJ?1=%?.G_#5?P._Z
M'G2/_ F/_&C_ (:K^!W_ $/.D?\ @3'_ (T>RJ_\^Y_^ OR\O-&?^L.0_P#0
MXRW_ ,+</_\ +/-?>?1=%?.G_#5?P._Z'G2/_ F/_&C_ (:K^!W_ $/.D?\
M@3'_ (T>RJ_\^Y_^ OR\O-!_K#D/_0XRW_PMP_\ \L\U]Y]%T5\Z?\-5_ [_
M *'G2/\ P)C_ ,:/^&J_@=_T/.D?^!,?^-'LJO\ S[G_ . OR\O-!_K#D/\
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M]*_XB1X??]%!E?X__*S]/_\ A'=!_P"@/IW_ ("0_P#Q%'_".Z#_ - ?3O\
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MZE"I%26VTE?EDNC305')V_'^E25')V_'^E2=H\=!]!_*OY;_ /@J-_R7>?\
MZX?^S&OZD!T'T'\J_EO_ ."HW_)=Y_\ KA_[,:]'+/\ >'_@9^&?2"_Y(5?]
MC/"_E,_-W1_^1B\-_P#8;L/_ $<E?VF?L^?\D@\$_P#8&M/_ $1%7\6>C_\
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M -%&OY-$ZR_]=7_F*_K+_P""CG_)N>N_]=C_ .BC7\FBG!E/I*]>_EG^[O\
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MA QC0LJ L1DL1TK^13]L/]H'4_C]\5-3U5KB4Z)I=U+!IL6]C"\2.Z9"9*=
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MY>OW>8?\3*3_ .B97_A6_+^[YO\ I:_VG_\ "U_AO_T.F@?^!T='_"U_AO\
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M?\FZR7UQ'_IP****XS]9"BBB@ J.6**=&BFC26-AAHY$5T8'C!5@0>/:I**
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M5&W=\JORI;O5EBBBBO,/WT*_!O\ X*O?L$>(?C"(_BU\-;)[S7K!6EU/3K=
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M )Y)('0&OF.7]M_]GN&22*7QKIZ/$[(X,\>0RG!Z$]Z+-[)_<.]M]#ZZHKY
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MV!OA)\*/%\'CKPAXM&NS1,KH+>_%W'E<8W;)7 Z=" <<]Z_263M^/]*_FO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
0%%%% !367=CG&/:BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lyra-20220510.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-09T20:33:08.5412636+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : cce1d8423df64e7f9cba5ad91da6fb82 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:lyra="http://lyratherapeutics.com/20220510" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://lyratherapeutics.com/20220510" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://lyratherapeutics.com/20220510/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lyra-20220510_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lyra-20220510_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lyra-20220510_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-09T20:33:08.5412636+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : cce1d8423df64e7f9cba5ad91da6fb82 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lyra-20220510_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-05-09T20:33:08.5412636+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : cce1d8423df64e7f9cba5ad91da6fb82 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lyratherapeutics.com/20220510/role/TemplateLink" xlink:href="lyra-20220510.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lyra-20220510.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139638670894808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 10,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LYRA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001327273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1700838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">480 Arsenal Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Watertown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">393-4600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LYRA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>lyra-8k_20220510_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lyra-20220510.xsd" xlink:type="simple"/>
    <context id="C_0001327273_20220510_20220510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001327273</identifier>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001327273_20220510_20220510" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001327273_20220510_20220510" id="F_000004">0001327273</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001327273_20220510_20220510" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001327273_20220510_20220510" id="F_000002">2022-05-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001327273_20220510_20220510" id="F_000003">LYRA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001327273_20220510_20220510" id="F_000008">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001327273_20220510_20220510" id="F_000007">001-39273</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001327273_20220510_20220510" id="F_000009">84-1700838</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001327273_20220510_20220510" id="F_000010">480 Arsenal Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0001327273_20220510_20220510" id="F_000011">Watertown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001327273_20220510_20220510" id="F_000012">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001327273_20220510_20220510" id="F_000013">02472</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001327273_20220510_20220510" id="F_000014">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001327273_20220510_20220510" id="F_000015">393-4600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001327273_20220510_20220510" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001327273_20220510_20220510" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001327273_20220510_20220510" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001327273_20220510_20220510" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001327273_20220510_20220510" id="F_000020">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001327273_20220510_20220510" id="F_000021">LYRA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001327273_20220510_20220510" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001327273_20220510_20220510" id="F_000005">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001327273_20220510_20220510" id="F_000006">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( .=%JE0'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ YT6J5+E":B_O    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ YT6J5)E<G",0!@  G"<  !,
M     ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #G1:I4
M2/ZWFDP$  #6$   &               @($."   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ YT6J5)^@&_"Q @  X@P   T
M     ( !D P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #G1:I4EXJ[',
M   3 @  "P              @ %L#P  7W)E;',O+G)E;'-02P$"% ,4
M" #G1:I4'#AEZC\!   \ @  #P              @ %5$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ YT6J5"0>FZ*M    ^ $  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
MYT6J5&60>9(9 0  SP,  !,              ( !IA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  \!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lyra-8k_20220510.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="lyra-8k_20220510.htm">lyra-8k_20220510.htm</File>
    <File>lyra-20220510.xsd</File>
    <File>lyra-20220510_lab.xml</File>
    <File>lyra-20220510_pre.xml</File>
    <File>lyra-ex991_24.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lyra-8k_20220510.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "lyra-8k_20220510.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lyra-20220510_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lyra-20220510_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lyra-20220510.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lyra",
   "nsuri": "http://lyratherapeutics.com/20220510",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "lyra-8k_20220510.htm",
      "contextRef": "C_0001327273_20220510_20220510",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "lyra-8k_20220510.htm",
      "contextRef": "C_0001327273_20220510_20220510",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://lyratherapeutics.com/20220510/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-22-019094-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-019094-xbrl.zip
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M74.24Y4HS*^?O2L)! @**@H>_"))O7;M=^W:53GYQW#@$O+ A.2^=UHP=:-
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M]LS_UU%]1_\WI#\*5EXNQ,R!S<7I$%N!M:(LDO^BTO=(@R*RXJ]P;)1)W.G
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M!(<"^EOX/)[$$4431T!;Q8MB$73\U00=PM^.!5S0@689S=CI::LJ3.(+-FX
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M&4/[ERI/27&37<+S+F^T<XC+ $\_<;%05FJO3KZ<?WK=D_.OA9B@XB4@1K/
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MGO]U?]7P8R52%](DYFMX0UY7-$?]/_^C%Q=ZGO\-(H0I^235 J> FK4R#*9
M:F)MJ^!725Z7Z31-HP?OAU:556.+)0S@),8HHUJ#(&S]^9^Y/\H3M$1AY](J
M9Z<I7GF.KO_ZD^$;1Y>O-;BB6$._4+A$).T ]$%@BLNES_\6[?SSEXM]",M+
M"##7,@1BS?77\%P(]Z\Y_Z:9=G^E(%2%%2W'036%I*:0U!12FV+.5DTAG68%
M>-EQ@'A[UMV'2=Z=G,))RG&:4P]SZU*9=0,Q<I4TLR\RAIE+7EIZA$RVD4M!
M$;_$\#1A^S><%'WM'6;N36]O$I\P4II=0.*B[=,YFJ8#?_;/^S)YJB[R$9];
M#\/9H\LTC^[-*EQ8IY)Y6UQ,^51R!LMR=3EUA=F[8)TB(-O/R*\_F59P!%'<
M?.XYM(7/R+D4TU,%P7T0V'>1])0*631=D!F4 Y+&^#93-ZV[$@05,K?56]PQ
M1:4062&R0N1UC[%V(?'>VX\$_/D0KAWT9AQ\@Q!B<4$DK4H$.*YQ,2%-R!@.
M,#-$,PZ@>?L@,Y8/H:=,$S,&4[1]*+UWLJ=CFAZ+"3EB 69^J6.0:P4?$GAY
M>3,<@=+A+U1CO!R!$\+T6UQ$&9 FZ0=3?7&11B A+V[D$HUHLGEP=W,G<<!L
M7@GF\>9#:!OE<VB>$MQ)T'S2+)XT^PODZV[M_%TX/I>#Y.ESO9S*HZRC_\"]
M4AXBY_C.+O>:#*0IQB]T:@;C(8I!"Y'IR+A%1^"[V=>TBR9W>[('9[R0MI+Z
M99?%)H>9=S<OPZAJ'][VV.R9I^\Y<->WDK&YUFVR1L*JGN3>;> J\?H^%;</
MIMH3"CZ'N&:ZMRB!'8D$U]ZM^R/!!U^_T4CP18RPM@6")YA6BQ,"(K^6_U4G
MH)5Q4O%X>^!X<ZW<ORP_P\2<9M>2!8Y@G#3=DUN1BR:GM[G"=OK>^(HF5[B2
MW]]SRH<1($?S=$/NQ16IW+A%*[D2^Y!G\WP6LK0AWEC(TIX$*M/D\.5L\+G,
MG28N*T7:\%RFL0R69E*"QYOOQ/9JN 93G)HT8;$A>C$_6,V-O.#1JO!0X:'"
MPR[AX1DON4 [1"$VW< @$"(K^;04Q3U%*.[ 27^*6O*3"516^1@HIT@J/QF_
MK21# "\.7%],R2!2]F]=;E_L_X58"J$%5MP0$SN A& 5H!2-%6)_=72# #NY
M!IX^22,==[HWV?P\*Q(4$5AU'1-:U2*K=WH]'X[2_(;S_8*G@OE/Y">"#8#*
M.I4;:_(2D'1\55-/9#&A%E"5\X5J.Z6"UI<\\!6T*FA5T-HE:/T'ST2Y$K%Y
MDPW!E^.R@D@R7 +7^9(]@L'-$LY^\!"06GVC!4 *J!GSLI2\=0'XY@!Q#)<3
M(!2PJ!#N)8\_A7 *X13"=0GA+F0^UJ1HP#-P1L/LVP]AG?<8TJ@@Y04;O((4
M!2D*4KH$*9]YI:6XNG4?,R+E! GTS8/%>O)?9DM4>WTW6$.)ZA4;YS\Q.:<%
MI7B.H[RN[BCQ^D-U(5>423MK=-];=QLS #=?:KOW<)WMQ:K9T&]1H!KG%_"A
MLE8%GMN3-0OE,\V628:$#GC9%XOK?R_O:&4B>U@D^"I,R-2B)!=]KL1K8* -
MM)*2. 9#Q\5Z311CY1R]#$])">:!M29DZ8KO<K9'@SZ5\ #L>Y[>P 7[K*@O
MFR3$[W(MOA$LM(S612'*I28CL1^RR2F<ZJ IC#J6!.-\-"FI>ELI\KDBY)B3
MR#CN5I4+#HW,4780M==Y#0_$QLDWW@C/6X_$B1#0'Y$TB^XX3?-K6>J_A&_0
M,\R'3+(K4L+3L+KN_NTC3%7'4-4Q-H%1+7; N2@_/C<)G&?2+VD#S#V_SF^K
MM@PC'"='&Z<\NQ+9[)+'4Q)$V9H;L5]=)#+!77%*AN"-<G"KC1.=[&HGT"]2
M@J\4^=.\;&JSIYPPZ71YE*1))>E\DY<MO<CL;O=A7D0)YB?Q\G!:"CL61:?'
MN[&TF=U8TQUBI19Q,5, C:W)S(ZKA\\CZ<V6T>O=\:BY)'J1-%[PL7>==&><
M2=]DC]]1GWOR_D=&L&*Q]I'WC&L2W&$(BQY<[""8+Z@-TJ^+28[8W'X"V3V)
M]IC-W]3:QLI2,<&3>P3N8E7Q<8U+ !4P"KD5\'?0ZA#WT(-=H=U7(ND-4 RE
M=)6421-O/;+'>+ ?'M$W"W-]0,1'/F9:B%,"E%;CYKXGM&B1X8BJFHC%&#\E
MV3?./F2/;-MC#0=[\6QMOH#P"&#LL7:XB2"YE5G]>7%-"K;_,<^_H5,Y!Q<H
MAL(=M.&93AY[=+SPB*Y?#))25#@3V29BN&+$!^&W(->BNVG3W7+271%6-PZQ
M*;8S!H^O34KI.7I4X?RUC_#M4NXY/N,BG#Z6Y=Z,('#ZVG&:SCZZ>?W8Z2\U
M3[@DEHM 7ZX+HK,#EP.&C,FY@'58T%<X*\S!T<I!7J=,[N[)\/B/0CC"N_HV
M>P3$3+,*?@G7BX[B 0@S1YR-DULQL75RUDDMX?2N[-NEQ-N>>.QL:+_LX7O-
M=J29_4N N+4@._?NYIY@X\/WCW&M@3D)4ZNZLE=3R8G-3A#;86_D-,UXR]AX
M3]MDS]0*^\]6VV36#$*I [E-:^6F_]AVKKGM6Z][8P<MFC@OWU4;="L-G3Q8
MG!H%]D)$''8C=N21D:B.W1R%40Y(,=F=-\7_Z5D:MYR?T5]96C(.F1D=^+*,
M)^(@*["V85(**EYHES4&DQ5'ZXW$*2=7>0H!U[<LO\Z$INI,_@S<^ILH5$UY
M@0Y N([I\5C3XUQP4.=%<\S($ 8@)74IJQM,R3(FWTU/RNKA%)X(3#!['9H%
MD4O"KYK&RVQV%!"J$S,7DCCF(AH4YH#S&G$MI+O2\_AWX;%PID"T.TW@QZ;D
MY$I^1XH*'5R:#!.9 =CL2!T3;'GVDO!O0@XSO1=D 9Z% >U\1(Y3IB!4B.K%
MSDU1=#V76ABG^LL=F&!:S;63"=8<JV!R82U2%D<+$L^X=*NSFQ)P3\"X  7$
MBJ@L[%6$Q9T@J,2G+3YFW./I>J'TYS='#_0XR^5TSI4\Q@I]9WG//7\O[XJA
M8= @3N*,A^!48NS.\*HC;2R36]LRT\EF[&,=.G@HSH?Q.!;'Q**8$?63^&;6
M"\.58'["4Q:X51!\SG@:;:&EBSU;R (%0_VK3AJ@6ZW;<ED6\XZ$_P3?O2_R
M<H9"@0VN)876E'5#:C49J[?)^??WQQ-9P(/DKE[95GG3V"7>VS*<'ROCF^9P
M(M&G:>5T_!#B#&'$CNZ\BEZ_,E\C4M>I)+;2((BH/C( K%XTMB2;\:!Y)%HU
MD=PMSP&Q@P;%0('&R\.20&$\([+B+#(,Z2A2?IF4J0AZCIICD'!&,AG7W"MO
M2ACW@EK!Y5@<5Y[FBG_&&2F<DYQ[V>PX%L<O5<GTX?.2GS&[65.:J_IRK]"O
M 2+ XD>X\UG098#"IE8OQ_-<Q7X?.:0OL0!<-BY96%>#O GZQ-F!XO@$> 1P
M: S.\!BI",\-A-?+XFY@6 SDC:%0P9-A5!>E#!!P'CF53X%821Q%-<I3W&T$
M8FFDAJUH'.\8]G#F=U2A5SZ:="Q-QDI.R759)_>Z!0PIL?FBNTG!Y+D6,XYP
MFMHMHK0Q:L@+$A$H-KGRTS/%  [V)P.TK,#'CS.^YT?MHGEB6R3"++9&;,'/
M1/>D?^!/>?Z<^0NKD5'W1$]B)E?DLR<B*)>IZ2DX[KS)4101.$[&#Y+1O>T?
M#WHLH@@2!FN@:"E4G@LVX^2$4<]HN!F6L\T0B-O8C9C5RBM.%[T[7,I3+ 5=
MR]DAP!/H:"'V7<^]H.#BF=_X#:)ZF6<93X6+S\<'$&JB6&:,,#ZYXDA$"0G%
MO$4Y"R=F1L:Q[[0=$$-=5X.YL9P1,!]<UTA*@C6M,;+G10%#IY2G)4*(4"Y&
MTPT"215D,8P%Q)CJFO-F)N//;P7RILEDA_SAK :_0U[?9O)-B25H)^/#A,HX
M2D0J)U_^^>']OA' FY Z$88K%2CJIE3W? ^CNL0HOXG6)KO^9HG4_ VWFN5\
MVW#0\V5G-7=2#:(+H"P$E'(11;C?M$:-BWF[J,1X481T1PO^LVP*/DV<_<RT
M%D*?+!XNHSULQ30:$7\8U3 \Z,1GR(-7;L8>'.V!IJ24YQE#<],) 1Y/X=T6
MUZJ%$;4P\J,+(P^^<0M33*NRRC&O Z](:T&?Y*%%P@,0257VSH E:K_+*_?&
M_';J'QXYD]D4Z #']N@-<>+43&C1[SB?9>C[CWWS8]\8@X>;G@@E??OY:7/&
MU),FL_?>RO.W'WE3[[$MQVR<)T_88V @'26>W85'8]PA HE4<BI@GOS+- %D
M]+,<OYGHR<66!)%2L I)AR<P?OO$9%\[1@BH(?*[Y_Z"-\=)S"#.W\O)#$U3
M8$ "/J*8^'GY5?^:%'2<I9WBY OL;CUB$@+O;PQ@;8E4KBGXW%0U% 0&P+L2
M(S$EB5C; ]8"F-=,XZ)$(6+,>QK'+1Y)+- 6L%0L"UW)>5RA"M0?'CY;3D]_
M[3^0GV<NK,O>[@EGG?[,*LIF\G8VDCK5SE7J#^.3@T]PGIY6AV^B0CMX>UQ<
M L\?'XXG/S,-<]_5=8@C=5-^@FMY_T/PTE%SY>QJ7O>$^8FSA"Q(\O^0:E#<
M9-JGO  ^(#\+#'O?U.U]US8:27Z35_T/C-@;]!L9,(&\^+9Y<3Y<]:N)"#?<
M@ [&S6L*&5_J&]\0(-I#>%]X?/KARY]8W/$,MY@ W?L*>GJ':A)_,3!P)VO0
MRQW)KZM5K'ZBZ_GX[[-C[>*/T[/CKZ=_7GPX.>]I'SZ?X&;.!\;GB^GA1*\G
M7SZ??_GXX?WQQ>G[\/P"OGTZ_7QQ'G[Y"KV_^ !_#4^^?/IZ)M7[Q-O .3/<
MKL3039=Y*J9(V<S2/X9H7R:3'KLCYE=U1FJ&:S&O=ZA3(LC-ZQ*X!=;C^([3
MQ<UBJ9AK!I(@?\-3\EXOCIIG/J?VGE/ GK*WK-F8(G4RF:UXQ$ZS\2W-I(9L
MV/)VJBG:B7?+W0C8Y_$'9^)VO>\Y,Q]>H"G,?_1N*B[9%D_O!^X"1CYH6[-[
M(O#W>5'C!S/"EMM9)L@01Y08@4-#SZ%!:%N>$?H\X*'K182XKA]Y;KS@/D(>
MV90X7A3Z)+)#F]AF& 2F@7?;IDEY$#MD\1[FNLSS#!TN#^"+"R^+F&N&#K5L
M"QK@6;:^> ^-=+A8]T*;.BRT8P/NL7TW=!FW?$JI;1C^4MMTXOM.# ^V7"NT
MG<@,?=>S0NX;L>58>FSYUN(]MA>Y)EP?4C<&&3@$>F:99AB[D14QDSEV9"Z]
MAT?4-.PXA*_8*0(RB ,O]*@?0*,=)Z!L\9Z 1G%L<>A 3.+0-GT21I1[(:.N
MR74_L&W#7KS'-)GI>]0*K<!V0<*,A8'NPQ?J.-1UB U=7+J',H\:G(>!&X,,
M/.@/T:D=$DH)-3T_8'1)IY3&/(@\N,>VH&V![84^96[HZR:Q2,!U3U^Z)W(=
M&GF6%1I> .^)=!?T ^JRJ,]]8A+;BHRE]\2F;IG4!(/0"=A!'(=1'% 0'O$M
M$$&D&TMR@TX2G7DLM#S= 5F[+(Q\RP[]R#:Y[4+SV%+;3.@-#;@5QKH=0=M<
M'W0:6:$/%N&Z)K6B:$END6UP:IH@J-B >]P 7A& M1I49Y$3VS!"&CNX;\.E
M'*?K=!)&W[77[R.VW4?3O&V3ZJYW&R[H8+<!]>P.=AL&\@; ?MM]5 .Y.]UN
MST ^D'4CBC5)8"Y<;SC*N$.")&OR0DW0,MQLG54_//6UHEAF>>6,H/R%T-]T
M#,/#<,>T3 AA?3<. X.0D%D0Q]LQ#8BW%%[[$!WZ&+[Y%L3_$";R,-)-%OH&
M,;EI^BX$:DMA50R1'2402U(/Z ($\R'&VZ'G.2Y$OGI$/&?Q'BMV&2407D<Z
M@[91SX-@EOLA#3P7WNI:EL\7[]&!DD0.Q(6VX< 7WPX@XH7 -.(0GD,7*6=+
M(9\/T;T3^SX$X@&$EHS!Y;;CAZ[-#0IQL@'?E_KCQ)&O<R.DMH7A-8/0T@R
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MNS]*5-IA>_R2PHKVZ41AQ4JG% <**]HU2G:(WK5<],T.M9DE+D7O.@,/:J?
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M<)A40XXG:F%1>0J7@1QX1A4=ZXSS5WF)*B^Q4QI08*K(U X)5^4FJMS$#BE
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MWZ#O@VJ8P@__'U!+ 0(4 Q0    ( .=%JE1PUAI)O@0  'H6   1
M      "  0    !L>7)A+3(P,C(P-3$P+GAS9%!+ 0(4 Q0    ( .=%JE3U
M5AX[*P<  $%,   5              "  >T$  !L>7)A+3(P,C(P-3$P7VQA
M8BYX;6Q02P$"% ,4    " #G1:I4+?T%0A4%  " +0  %0
M@ %+#   ;'ER82TR,#(R,#4Q,%]P<F4N>&UL4$L! A0#%     @ YT6J5&47
MC@ C$0  <9<  !0              ( !DQ$  &QY<F$M.&M?,C R,C U,3 N
M:'1M4$L! A0#%     @ YT6J5!5ED\=R,   21,# !$              ( !
KZ"(  &QY<F$M97@Y.3%?,C0N:'1M4$L%!@     %  4 1@$  (E3      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
